Oscar Health, Inc.
NYSE:OSCRMedical - Healthcare Plans
+$0.05 today
- Market cap
- $7.15B
- Beta
- 2.39
- P/E (TTM)
- -214.2
- EPS (TTM)
- -$0.13
Volume 7.38M
Average 7.51M
OSCR Other Financing Activities
Financing cash flows not reported separately.
Oscar Health, Inc.NYSE: OSCR
Other Financing Activities · Q2 FY2026 · quarter ended Jun 2026
Other financing activities turns positive
Q2 FY2026 other financing activities was $13.3M, compared with -$1.43M a year earlier. Trailing-twelve-month other financing activities was $6.81M. Over 3 fiscal years it compounded at -8.0% a year.
Context
- Other financing activities amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Other financing activities increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly other financing activities holds near $13.3M or moves back toward the trailing-twelve-month quarterly average of $1.7M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Financing Activities history
USD · from the cash flow
- Latest · FY2025
- (4.04M) USD
- Year-over-year change
- —
| Period | Period end | Other Financing Activities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (4.04M) | — |
| FY2024 | 2024-12-31 | 0 | -100.0% |
| FY2023 | 2023-12-31 | 2.49M | +148.0% |
| FY2022 | 2022-12-31 | (5.19M) | -111.9% |
| FY2021 | 2021-12-31 | 43.56M | — |
Other Financing Activities vs competitors
How OSCR compares with its peers on the latest reported figures
- OSCR's LTM Jun 2026 other financing activities of $6.81M is the 7th largest of the 8 companies compared; the peer median is $10M.
- Its year-over-year change of +397.5% is the highest of 7, against a peer median of -32.2%.
- Other financing activities amounts to 0.0% of revenue for OSCR, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $798M | +14.5% | +109.5% | 0.3% | |
| LTM Sep 2026 | $225M | -35.9% | -45.7% | 0.1% | |
| LTM Jun 2026 | $204M | -232.5% | +167.9% | 0.0% | |
| LTM Sep 2026 | $23M | -8.0% | -42.0% | 0.1% | |
| LTM Jun 2026 | $10M | -28.6% | -22.6% | 0.0% | |
| LTM Jun 2026 | $9.13M | — | — | 0.4% | |
| LTM Jun 2026 | $6.81M | +397.5% | -8.0% | 0.0% | |
| LTM Mar 2026 | $1.66M | -1385.3% | -82.9% | 0.0% | |
| Peer median (excluding OSCR) | $10M | -32.2% | -32.3% | 0.1% | |
Competitors are the stored peer set for OSCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (571.43M) | (609.55M) | (270.59M) | 26.12M | (442.9M) |
| Depreciation & Amortization | 14.61M | 15.28M | 30.69M | 32.15M | 28.89M |
| Deferred Income Tax | (101K) | (165K) | 58K | (2.34M) | 2.45M |
| Stock-Based Compensation | 86.3M | 112.33M | 159.68M | 109.82M | 87.65M |
| Change in Working Capital | 247.7M | 855M | (192.09M) | 838.86M | 1.46B |
| Accounts Receivables | 80.45M | (551.15M) | 636.23M | (177.52M) | 98.57M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (39.46M) | 280.23M | (395.81M) | 133.09M | 167.72M |
| Other Working Capital | 206.71M | 1.13B | (432.51M) | 883.29M | 1.19B |
| Other Non-Cash Items | 41.19M | 7.46M | 86K | (26.42M) | (40.24M) |
| Operating Cash Flow | (181.75M) | 380.35M | (272.16M) | 978.19M | 1.09B |
| Capital Expenditures | (25.89M) | (29.01M) | (25.58M) | (27.9M) | (36.37M) |
| Acquisitions (Net) | 7.23M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (1.81B) | (1.19B) | (836.98M) | (2.13B) | (1.01B) |
| Sales of Investments | 1.05B | 994.08M | 1.44B | 770.04M | 804.96M |
| Other Investing Activities | (555K) | 1.12M | (2.28M) | 3.93M | 4.28M |
| Investing Cash Flow | (774.52M) | (226.52M) | 577.19M | (1.39B) | (241.06M) |
| Debt Repayment | (153.17M) | 305M | 0 | 0 | 348.21M |
| Common Stock Issued | 1.35B | 1.3M | 3.96M | 68.39M | 55.03M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 43.56M | (5.19M) | 2.49M | 0 | (4.04M) |
| Financing Cash Flow | 1.24B | 301.11M | 6.45M | 68.39M | 399.21M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 282.45M | 454.94M | 311.47M | (340.85M) | 1.25B |
| Free Cash Flow | (207.63M) | 351.34M | (297.74M) | 950.3M | 1.06B |
Oscar Health, Inc.
NYSE:OSCR
Intrinsic Alpha fair value
Locked
Current Price
$27.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.